On Feb. 17, 2023, Vanguard announced that William Coleman has been promoted to a leadership role and will no longer comanage the LifeStrategy series. He will be replaced by Roger Aliaga-Diaz, Michael Roach, and Aurelie Denis. All three were already contributing to the series, with Aliaga-Diaz being a key contributor to the research and asset allocation of this series. Roach and Denis joined the firm in 1998 and 2016, respectively, and Roach now oversees the management of multi-asset products in the newly created head of Multi-Asset Portfolio Management role. A team-based approach, continuity of senior management, and the new comanagers’ appropriate credentials eliminate concern over the change. The strategy maintains its Above Average People rating and Morningstar Analyst Rating of Silver across all shares.
- NAV / 1-Day Return 14.30 / 0.14 %
- Total Assets 4.3 Bil
-
Adj. Expense Ratio
0.110%
- Expense Ratio 0.110%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Conservative Allocation
- Investment Style Large Blend
- Credit Quality / Interest Rate Sensitivity Medium / Moderate
- Status Open
- TTM Yield 2.28%
- Turnover 26%
Morningstar’s Analysis VASIX
Will VASIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings 0
- Bond Holdings 0
- Other Holdings 6
- % Assets in Top 10 Holdings 99.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
Vanguard Total Bond Market II Idx Inv
55.72
2,393,237,534
—
Vanguard Total Intl Bd II Idx Investor
24.05
1,032,851,832
—
Vanguard Total Stock Mkt Idx Inv
11.62
499,216,477
—
Vanguard Total Intl Stock Index Inv
7.92
340,184,875
—
Mktliq 12/31/2049
0.67
28,688,322
Cash and Equivalents
Us Dollar
0.02
818,241
Cash and Equivalents